Vanderbilt Basic Sciences

  • Vanderbilt University

    Resistance to COVID-19 drug detected in lab study

    The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. The results of the laboratory study led by researchers at Vanderbilt University Medical Center and published April 28 in the journal Science… Read More

    May. 12, 2022

  • Vanderbilt University

    Resistance to COVID-19 drug detected in lab study

    The virus that causes COVID-19 can develop partial resistance to the antiviral drug remdesivir during infection of cultured cells in the laboratory by more than one mechanism. The results of the laboratory study led by researchers at Vanderbilt University Medical Center and published April 28 in the journal Science… Read More

    May. 12, 2022

  • Six biomedical Ph.D. students awarded prestigious NSF Graduate Research Fellowships

    Six biomedical Ph.D. students awarded prestigious NSF Graduate Research Fellowships

    From left to right, top to bottom: Minna Apostolova, Blake Baleami, Andreanna Burman, Drew Dixson, Kevin McCarty, Teresa Piedad Torres, Jose Zepeda, Kaeli Bryant, Julissa Burgos, Heather Hartmann, Reese Martin, Zach Sanchez. By Emily Overway The National Science Foundation Graduate Research Fellowship Program… Read More

    May. 10, 2022

  • Vanderbilt University

    Cryo-EM reveals the molecular mechanism of IP3 receptor channel opening

    Research led by co-first authors Emily Schmitz, a graduate student in the Chemical and Physical Biology program, and Hirohide Takahashi, a research instructor in molecular physiology and biophysics, identified the structure of the human type-3 inositol 1,4,5-triphosphate, or IP3, receptor in several conformations using cryo-electron microscopy. Schmitz and Takahasi, who… Read More

    May. 9, 2022

  • Vanderbilt University

    Faculty awards honor teaching, clinical, research excellence

    The 2022 Vanderbilt University School of Medicine Academic Enterprise Awards for Excellence in Teaching, Extraordinary Performance of Clinical Service, and Outstanding Contributions to Research were presented April 29 during the annual spring faculty meeting. The recipients include…… Read More

    May. 5, 2022

  • Vanderbilt University

    The Skaar lab discovers how bacterial pathogen survives without water

    The pathogen Acinetobacter baumannii can survive on hospital surfaces — without water — for months, an ability that has helped it become a leading cause of hospital-acquired infections. Now, a team of Vanderbilt researchers has discovered a mechanism this bug uses to live in a dried-out state: it produces “hydrophilin”… Read More

    May. 5, 2022

  • New faculty Nancy Carrasco - Molecular Physiology, in her lab at Light Hall for Vanderbilt Magazine.

    Carrasco elected to American Academy of Arts and Sciences

    The American Academy of Arts and Sciences announced today that Dr. Nancy Carrasco, Joe C. Davis Professor of Biomedical Science and professor and chair of molecular physiology and biophysics, has been elected as one of its new members. Carrasco was elected to… Read More

    Apr. 29, 2022

  • Vanderbilt University

    Ramadan from the inside

    By Ansari Aleem Ansari Aleem, Ph.D. For me, Ramadan—the month of fasting—is about the Quran, worship, prayer, and generosity. Fasting is one of the pillars of Islam and is mandatory for a healthy adult Muslim. I have been practicing fasting ever since I can remember. For me, fasting is a… Read More

    Apr. 26, 2022

  • Vanderbilt University

    Collaborative research lays groundwork for potential treatment of a rare and deadly type of cancer

    A collaborative project between the labs of William Tansey, Ingram Professor of Cancer Research and professor of cell and developmental biology and biochemistry, and Stephen Fesik, Orrin H. Ingram II Chair in Cancer Research and professor of biochemistry, chemistry and pharmacology, has… Read More

    Apr. 25, 2022

  • Vanderbilt University

    Prothena and Warren Center for Neuroscience Drug Discovery collaborate on new Alzheimer’s disease therapeutics

    Prothena and the Warren Center for Neuroscience Drug Discovery have entered into a collaborative research agreement to develop new small molecule therapeutics for the treatment of Alzheimer’s disease in individuals with Down syndrome. Down syndrome is a condition in which a person’s having… Read More

    Apr. 22, 2022